Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group
21 nov. 2024 05h30 HE
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group
Global Down Syndrome Foundation Raises $2.5 Million at Star-Studded Be Beautiful Be Yourself Fashion Show
19 nov. 2024 14h27 HE
|
Global Down Syndrome Foundation
Denver, Nov. 19, 2024 (GLOBE NEWSWIRE) -- On Saturday, November 16, Global Down Syndrome Foundation (GLOBAL) raised $2.5 million at their Be Beautiful Be Yourself Fashion Show, held at the Sheraton...
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
13 nov. 2024 08h00 HE
|
PRISM MarketView
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
12 nov. 2024 16h05 HE
|
OncoCyte Corporation
Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025
American Academy of Pediatrics & Global Down Syndrome Foundation Collaborate on Down Syndrome Recommendations
12 nov. 2024 14h21 HE
|
Global Down Syndrome Foundation
Denver, Itasca, IL, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Global Down Syndrome Foundation (GLOBAL), the leading Down syndrome research, medical care and advocacy non-profit in the U.S., and the American...
Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform
12 nov. 2024 05h30 HE
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
06 nov. 2024 16h45 HE
|
OncoCyte Corporation
Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12
Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split
01 nov. 2024 16h30 HE
|
Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split
Immunophotonics to Present at the 2024 ThinkEquity Conference
28 oct. 2024 08h30 HE
|
Immunophotonics, Inc.
Immunophotonics to Present at the 2024 ThinkEquity Conference
NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference
24 oct. 2024 09h00 HE
|
NeuroOne Medical Technologies
NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference